[S. Miyamoto, G. E. Duncan, C. E. Marx and J. A. Lieberman, Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs, Mol. Psychiatry 10 (2005) 79-104; DOI: 10.1038/sj.mp.4001556.10.1038/sj.mp.4001556]Search in Google Scholar
[S. Natesan, G. E. Reckless, K. B. Barlow, J. N. Nobrega and S. Kapur, Amisulpride the ‘atypical’ atypical antipsychotic-comparison to haloperidol, risperidone and clozapine, Schizophr. Res. 105 (2008) 224-235; DOI: 10.1016/j.schres.2008.07.005.10.1016/j.schres.2008.07.005]Search in Google Scholar
[V. Bigliani, R. S. Mulligan, P. D. Acton, D. Visvikis, P. J. Ellm, C. Stephenson, R. W. Kerwin and L. S. Pilowsky, In vivo occupancy of striatal and temporal cortical D2/D3 dopamine receptors by typical antipsychotic drugs. [123I] epidepride single photon emission tomography (SPET) study, Brit. J. Psychiat. 175 (1999) 231-238; DOI: 10.1192/bjp.175.3.231.10.1192/bjp.175.3.231]Search in Google Scholar
[S. Leucht, C. Corves, D. Arbter, R. R. Engel, C. Li and J. M. Davis, Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis, Lancet 373 (2009) 31-41; DOI: 10.1016/S0140-6736(08)61764-X.10.1016/S0140-6736(08)61764-X]Search in Google Scholar
[M. L. Wadenberg, S. Kapur, A. Soliman, C. Jones and F. Vaccarino, Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats, Psychopharmacology 150 (2000) 422-429; DOI: 10.1007/s002130000466.10.1007/s002130000466]Search in Google Scholar
[J. T. Trevitt, M. Lyons, J. Aberman, D. Carriero, M. Finn and J. D. Salamone, Effects of clozapine, thioridazine, risperidone and haloperidol on behavioral tests related to extrapyramidal motor function, Psychopharmacology 132 (1997) 74-81; DOI: 10.1007/s002130050322.10.1007/s002130050322]Search in Google Scholar
[S. Kapur and P. Seeman, Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics?: A new hypothesis, Am. J. Psychiat. 158 (2000) 360-369; DOI: 10.1176/appi.ajp.158.3.360.10.1176/appi.ajp.158.3.360]Search in Google Scholar
[A. Newman, C. Chaput, L. Verriele and M. J. Millan, Clozapine is a partial agonist at cloned human serotonin 5-HT1A receptors, Neuropharmacology 35 (1996) 119-121; DOI: 10.1016/0028-3908 (95)00170-0.]Search in Google Scholar
[S. Szymanski, J. Lieberman, S. Pollack, R. Munne, A. Safferman, J. Kane, M. Kronig and T. Cooper, The dopamine-serotonin relationship in clozapine response, Psychopharmacology 112 (1993) S85-S89; DOI: 10.1007/BF02245011.10.1007/BF02245011]Search in Google Scholar
[M. Campbell, P. I. Young, D. N. Bateman, J. M. Smith and S. H. Thomas, The use of atypical antipsychotics in the management of schizophrenia, Br. J. Clin. Pharmaco. 47 (1999) 13-22; DOI: 10.1046/j.1365-2125.1999.00849.x.10.1046/j.1365-2125.1999.00849.x]Search in Google Scholar
[R. Kumar, G. Palit and B. N. Dhawan, Comparative behavioral effects of typical and atypical antipsychotic drugs in rhesus monkey, Eur. J. Pharmacol. 462 (2003) 133-138; DOI: 10.1016/S0014-2999(02)02957-6.10.1016/S0014-2999(02)02957-6]Search in Google Scholar
[R. A. Bressan, K. Erlandsson, H. M. Jones, R. S. Mulligan, P. J. Ell and L. S. Pilowsky, Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [123I]-epidepride SPET study, J. Clin. Psychopharm. 23 (2003) 5-14; DOI: 10.1097/00004714-200302000-00002.10.1097/00004714-200302000-00002]Search in Google Scholar
[D. J. Haleem, F. Batool, N. H. Khan, N. Kamil, O. Ali, Z. S. Saify and M. A. Haleem, Differences in the effects of haloperidol and clozapine on brain serotonin and dopamine metabolism and on tests related to extrapyramidal functions in rats, Med. Sci. Monit. 8 (2002) 354-361.]Search in Google Scholar
[F. Batool, S. Ahmed and D. J. Haleem, Dietary supplementations of amino acids: evidence for enhanced serotonergic functions following haloperidol withdrawal in rat medial prefrontal cortex, J. Coll. Physicians Surg. Pak. 9 (2009) 139-145.]Search in Google Scholar
[D. J. Haleem, Z. S. Saify, S. Siddiqui, F. Batool and M. A. Haleem, Pre- and postsynaptic responses to 1-(1-naphthylpiperazine) following adaptation to stress in rats, Prog. Neuro-Psychoph. 26 (2002) 149-56; DOI: 10.1016/S0278-5846(01)00240-8.10.1016/S0278-5846(01)00240-8]Search in Google Scholar
[L. S. Pilowsky, D. C. Costa, P. J. Ell, N. P. Verhoeff, R. M. Murray and R. W. Kerwin, D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerized tomography study, Brit. J. Psychiat. 164 (1994) 16-26; DOI: 10.1192/bjp.164.1.16.10.1192/bjp.164.1.16]Search in Google Scholar
[Q. C. Meng, Y. F. Chen and S. Oparil, A simple method for concentration of biogenic amines and their metabolites from biological samples for analysis by HPLC-EC, Life Sci. 44 (1989) 1207-1213; DOI: 10.1016/0024-3205(89)90316-0.10.1016/0024-3205(89)90316-0]Search in Google Scholar
[N. Samad, F. Batool and D. J. Haleem, Neurochemical and behavioral effects of 8-OH-DPAT following exposure to restraint stress in rats, Pharmacol. Rep. 59 (2007) 173-180.]Search in Google Scholar
[J. de Jong, U. R. Tjaden, E. Visser and W. H. Meijer, Determination of serotonin and 5-hydroxy-indoleacetic acid in urine by reversed-phase ion-pair partition chromatography with fluorimetric detection, J. Chromatogr. 7 (1987) 85-94.10.1016/0378-4347(87)80268-2]Search in Google Scholar
[L. Farde, A. L. Nordstrom, F. A. Wiesel, S. Pauli, C. Halldin and G. Sedvall, Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects, Arch. Gen. Psychiat. 49 (1992) 538-544; DOI: 10.1016/0024-3205(78)90035-8.10.1016/0024-3205(78)90035-8]Search in Google Scholar
[T. J. Crow, E. C. Johnstone, A. J. Longden and F. Owen, Dopaminergic mechanisms in schizophrenia: the antipsychotic effect and the disease process, Life Sci. 23 (1978) 563-567; DOI: 10.1016/0024-3205(78)90035-8.10.1016/0024-3205(78)90035-8]Search in Google Scholar
[D. Pickar, T. P. Su, D. R. Weinberger, R. Coppola, A. K. Malhotra, M. B. Knable, K. S. Lee, J. Gorey, J. J. Bartko, A. Breier and J. Hsiao, Individual variation in D2 dopamine receptor occupancy in clozapine-treated patients, Am. J. Psychiat. 153 (1996) 1571-1578.10.1176/ajp.153.12.1571]Search in Google Scholar
[H. Y. Meltzer and M. Huang, In vivo actions of atypical antipsychotic drug on serotonergic and dopaminergic systems, Prog. Brain Res. 172 (2008) 177-197; DOI: 10.1016/S0079-6123(08)00909-6.10.1016/S0079-6123(08)00909-6]Search in Google Scholar
[X. Xiberas, J. L. Martinot, L. Mallet, E. Artiges, C. Loc'H, B. Mazière and M. L. Paillère-Martinot, Extrastriatal and striatal D2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia, Brit. J. Psychiat. 179 (2001) 503-508; DOI: 10.1192/bjp.179.6.503.10.1192/bjp.179.6.50311731352]Search in Google Scholar
[S. Nyberg, L. Farde, L. Eriksson, C. Halldin and B. Eriksson, 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone, Psychopharmacology 110 (1993) 265-272; DOI: 10.1007/BF02251280.10.1007/BF022512807530376]Search in Google Scholar